Erlotinib Completed Phase 1 Trials for Recurrent Gallbladder Cancer / Recurrent Gastrointestinal Carcinoid Tumor / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Stage IV Verrucous Carcinoma of the Larynx / Stage IV Adenoid Cystic Carcinoma of the Oral Cavity / Recurrent Extrahepatic Bile Duct Cancer / Stage IV Rectal Cancer / Recurrent Basal Cell Carcinoma of the Lip / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Unresectable Extrahepatic Bile Duct Cancer / Stage IV Esophageal Cancer / Small Intestine Adenocarcinoma / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Adenocarcinoma of the Rectum / Recurrent Anal Cancer / Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Recurrent Adult Primary Liver Cancer / Recurrent Salivary Gland Cancer / Recurrent Colon Cancer / Recurrent Lymphoepithelioma of the Nasopharynx / Recurrent Lymphoepithelioma of the Oropharynx / Small Intestine Lymphoma / Advanced Adult Primary Liver Cancer / Stage IV Lymphoepithelioma of the Nasopharynx / Recurrent Verrucous Carcinoma of the Larynx / Stage IV Lymphoepithelioma of the Oropharynx / Stage IV Salivary Gland Cancer / Carcinoma of the Appendix / Recurrent Adenoid Cystic Carcinoma of the Oral Cavity / Stage IV Squamous Cell Carcinoma of the Larynx / Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IV Basal Cell Carcinoma of the Lip / Recurrent Rectal Cancer / Metastatic Squamous Neck Cancer With Occult Primary / Recurrent Verrucous Carcinoma of the Oral Cavity / Stage IV Anal Cancer / Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Oropharynx / Small Intestine Leiomyosarcoma / Metastatic Colon Cancer / Adenocarcinoma of the Colon / Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Recurrent Esophageal Cancer / Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Recurrent Mucoepidermoid Carcinoma of the Oral Cavity / Stage IV Mucoepidermoid Carcinoma of the Oral Cavity / Stage IV Verrucous Carcinoma of the Oral Cavity / Advanced Gastric Cancer / Recurrent Small Intestine Cancer / Recurrent Pancreatic Cancer / Tongue Cancer / Stage IV Non-Small Cell Lung Cancer / Stage IV Pancreatic Cancer / Recurrent Squamous Cell Carcinoma of the Oropharynx / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Larynx / Metastatic Gastrointestinal Carcinoid Tumor / Non-Small Cell Lung Cancer Recurrent / Recurrent Metastatic Squamous Neck Cancer With Occult Primary / Recurrent Gastric Cancer / Gastrointestinal Stromal Tumors / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Unresectable Gallbladder Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00397384Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer